Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| WAY-325371 | C23H25NO4 | 444908-22-9 | Details |
| Hygric acid | C6H11NO2 | 475-11-6 | Details |
| Ensaculin | C26H32N2O5 | 155773-59-4 | Details |
| 6β-Prostaglandin I1 | C20H34O5 | 62770-50-7 | Details |
| (R)-CJ 11974 | 187281-35-2 | Details |
| UDP-Glucuronic Acid (sodium salt hydrate) | Details |
| ZEN-3694 | C19H19N5O | 1643947-30-1 | Details |
| 13,14-dihydro-15-keto Prostaglandin D1 | C20H34O5 | 1392219-79-2 | Details |
| CAY10443 | C17H15Cl2NO2 | 582314-48-5 | Details |
| CCD Lipid01 | C50H93NO9 | 1799316-64-5 | Details |
| 1-Tridecanol | C13H28O | 112-70-9 | Details |
| Bractoppin | C25H23FN4O | 2290527-07-8 | Details |
| REV 5901A | C22H26ClNO2 | 92532-23-5 | Details |
| CAY10506 | C20H26N2O4S3 | 292615-75-9 | Details |
| Alamandine TFA | 2863659-13-4 | Details |
| hTYR/AbTYR-IN-1 | C18H20N2O3 | 1625821-37-5 | Details |
| Myxochelin A | C20H24N2O7 | 120243-02-9 | Details |
| 2-tert-Butyl-1,4-benzoquinone | C10H12O2 | 3602-55-9 | Details |
| Bigelovin | C17H20O5 | 3668-14-2 | Details |
| L524-0366 | C13H13ClN4OS | 951612-19-4 | Details |
| Evixapodlin | C34H36Cl2N8O4 | 2374856-75-2 | Details |
| Ganaplacide phosphate | Details |
| N-acetyl-D-Lactosamine | C14H25NO11 | 32181-59-2 | Details |
| Myosin V-IN-1 | C29H26N6O3S | 1259177-59-7 | Details |
| Heteroclitin D | C27H30O8 | 140369-76-2 | Details |
| 5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE | C8H13N3S | 17899-49-9 | Details |
| A-943931 (hydrochloride hydrate) | Details |
| N-p-Tosyl-Gly-Pro-Lys-pNA (acetate) | C28H38N6O9S | 88793-79-7 | Details |
| (Z)-docos-13-en-1-ol | C22H44O | 629-98-1 | Details |
| TAK-418 | 1818252-53-7 | Details |
| Magnetite | Fe3O4 | 1309-38-2 | Details |
| BAY 1892005 | C11H8ClFN2OS | 2036352-13-1 | Details |
| alpha-Endorphin acetate | C77H120N18O26S | 59004-96-5 | Details |
| PtdIns-(3)-P1 (1,2-dioctanoyl) (sodium salt) | C25H49NaO16P2 | 299216-98-1 | Details |
| AG-270 | C30H27N5O2 | 2201056-66-6 | Details |
| AR-M 1896 Acetate | Details |
| URAT1 inhibitor 7 | C19H10ClFN4O3S | 1632002-28-8 | Details |
| Zinquin ethyl ester | C21H22N2O5S | 181530-09-6 | Details |
| 6-fluoro-3-(4-1,2,5,6-tetrahydropyridyl)indole | C13H13FN2 | 180161-14-2 | Details |
| Fluzoparib | C22H16F4N6O2 | 1358715-18-0 | Details |
| Dimethindene | C20H24N2 | 5636-83-9 | Details |
| A-966492 | C18H17FN4O | 934162-61-5 | Details |
| Fenaclon | C11H14ClNO | 306-20-7 | Details |
| JY-2 | C13H7Cl2N3O | 339103-05-8 | Details |
| 2,3-Indolobetulonic Acid | C36H49NO2 | 905837-93-6 | Details |
| HADA Hydrochloride | C13H13ClN2O6 | 2253733-10-5 | Details |
| Burnettramic Acid A aglycone | C35H61NO7 | 2396676-46-1 | Details |
| (±)-Hexanoylcarnitine chloride | C13H26ClNO4 | 6920-35-0 | Details |
| AA38-3 | C12H14N2O4 | 65815-76-1 | Details |
| Crobenetine | C25H33NO2 | 221019-25-6 | Details |
| SAG dihydrochloride | 2702366-44-5 | Details |
| Trehalose 6-phosphate potassium salt hydrate | Details |
| Nampt activator-1 | C16H17N3O3 | 701929-65-9 | Details |
| N-tridecanoyl-L-Homoserine lactone | C17H31NO3 | 878627-21-5 | Details |
| CB1R Allosteric modulator 3 | C22H17ClN2O2 | 2633686-36-7 | Details |
| HS271 | C21H24F3N5O2 | 2410393-15-4 | Details |
| C16 Ceramide | C34H67NO3 | 24696-26-2 | Details |
| 2-Fluoro-4-iodo benzonitrile | C7H3FIN | 137553-42-5 | Details |
| KX2-361 | C24H24FN3O2 | 897016-26-1 | Details |
| Ophiopojaponin C | C44H70O18 | 911819-08-4 | Details |
| G43 | C16H11N3O4S | 690693-02-8 | Details |
| GSK-1070916 | C30H33N7O | 942918-07-2 | Details |
| Motixafortide TFA(664334-36-5,Free) | Details |
| Compound 28 | C30H34N8O5 | 1062172-60-4 | Details |
| MS023 dihydrochloride | C17H26ClN3O | 1992047-64-9 | Details |
| CAY10563 | C9H4F3NO2S | Details |
| Aurintricarboxylic acid | C22H14O9 | 4431-00-9 | Details |
| Flecainide hydrochloride | C17H21ClF6N2O3 | 57415-44-8 | Details |
| Prostaglandin F2α 1,11-lactone | C20H32O4 | 62410-84-8 | Details |
| 2-Acetylthiazole | C5H5NOS | 24295-03-2 | Details |
| Cetyldimethylethylammonium Bromide | C20H44BrN | 124-03-8 | Details |
| 1-Isomangostin | C24H26O6 | 19275-44-6 | Details |
| B-HT 933 dihydrochloride | C9H16ClN3O | 36067-72-8 | Details |
| Trifludimoxazin | C16H11F3N4O4S | 1258836-72-4 | Details |
| FOLR1 Protein, Human, Recombinant (His) | Details |
| N,N-dimethyl Sphinganine (d18:0) | C20H43NO2 | 17267-46-8 | Details |
| Anticonvulsant agent 2 | C21H17ClN2 | 75220-84-7 | Details |
| CAY10677 | C25H37N5 | 1443253-20-0 | Details |
| RLLFT-NH2 acetate | Details |
| VU534 | C21H22FN3O3S2 | 923509-20-0 | Details |
| Neuroprotective agent 1 | C14H10F6N2O3 | 1878204-21-7 | Details |
| BDBM50597431 | 1629853-49-1 | Details |
| Pomalidomide-PEG2-OH | C17H19N3O6 | 2143097-10-1 | Details |
| Herquline A | C19H26N2O2 | 71812-08-3 | Details |
| Nornidulin | C19H15Cl3O5 | 33403-37-1 | Details |
| AGI-41998 tautomers | Details |
| Isbufylline | C11H16N4O2 | 90162-60-0 | Details |
| PBRM1-BD2-IN-8 | C15H13BrN2O | 2819989-75-6 | Details |
| BCR-ABL-IN-7 | C19H16FN3O3S | 688050-42-2 | Details |
| 5-HT3 antagonist 5 | C16H13N3O2 | 901599-43-7 | Details |
| Oleyl Mesylate | C19H38O3S | 35709-09-2 | Details |
| B2M/beta 2-Microglobulin Protein, Human, Recombinant (His) | Details |
| WAY-323061 | C25H21N5O2S | 550301-63-8 | Details |
| ARN19702 | C21H22FN3O3S2 | 1971937-18-4 | Details |
| PF-03382792 | C23H32FN3O4 | 1400811-63-3 | Details |
| D4R agonist-1 | 2826198-44-9 | Details |
| 5-hydroxy-3,7-dimethoxy-2-phenylchromen- | C17H14O5 | 70786-48-0 | Details |
| Miraculin Protein, Synsepalum dulcificum, Recombinant (His) | Details |
| Epitinib succinate | C28H32N6O6 | 2252334-12-4 | Details |
| Product Total： Product Page： | ||||
| 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 | ||||